Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China
- 407 Downloads
The purpose of this study was to identify clinical characteristics of Clostridium difficile infection (CDI) in patients with antibiotic-associated diarrhea (AAD). A prospective study was conducted among patients hospitalized in Fudan University Hospital Huashan from August 1, 2012 to July 31, 2013. Toxigenic C. difficile isolates were characterized by PCR ribotyping and multilocus sequence typing. AAD developed in 1.0 % (206/20437) of the antibiotic-treated hospitalized patients and toxigenic C. difficile was isolated from 30.6 % (63/206) of patients with AAD. The frequency of AAD was highest in the intensive care unit (10.7 %); however the proportion of CDI in AAD was highest in the Geriatric Unit (38 %). AAD ranged in severity from mild to moderate. One case with pseudomembranous colitis was identified. Use of carbapenems was found to significantly increase the risk of CDI (OR, 2.31; 95 % CI, 1.22–4.38; p = 0.011). Patient demographics, presumed risk factors, clinical manifestations and laboratory findings revealed no significant difference between patients with CDI and non-C. difficile AAD. Over 90 % of the patients with CDI or non-C. difficile AAD were cured. Two patients had CDI recurrence. Ribotype H was the dominant (18.8 %) genotype, followed by ribotype 012 and ribotype 017. C. difficile plays a significant role in AAD in our setting in China. Because the severity of diarrhea ranges from mild to moderate, it is difficult for Chinese clinicians to identify CDI from AAD patients, therefore CDI should be included in the routine differential diagnoses for hospitalized patients presenting with AAD.
KeywordsBerberine Multilocus Sequence Typing Moderate Diarrhea Diarrhea Onset Presume Risk Factor
This work was supported by a grant from the National Natural Science Foundation of China (no. 30973594 and no. 81101292) and Shanghai Pujiang Programme (no. 10PJ1401800). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Conflict of interest
- 6.Asha NJ, Tompkins D, Wilcox MH (2006) Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 44(8):2785–2791PubMedCrossRefPubMedCentralGoogle Scholar
- 7.Bauer MP, Kuijper EJ, van Dissel JT, European Society of Clinical Microbiology and Infectious Diseases (2009) European society of clinical microbiology and infectious diseases (ESCMID): treatment guidance document for clostridium difficile infection (CDI). Clin Microbiol Infect 15(12):1067–1079PubMedCrossRefGoogle Scholar
- 11.Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365(18):1693–1703PubMedCrossRefGoogle Scholar
- 12.Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorlí L, Martínez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A, Barcelona Clostridium difficile Study Group (2013) Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol 51(5):1465–1473PubMedCrossRefPubMedCentralGoogle Scholar
- 15.Chen J, Guo X (2006) Clinical characteristics, control and prevention of antibiotic—associated diarrhea. World Chin J Digestol 14(9):927–929Google Scholar
- 16.Wang Y, Lin J (2008) Clinical analysis of antibiotic associated diarrhea. Chin J Health Lab Technol 18(7):1393–1394Google Scholar
- 18.Hawkey PM, Marriott C, Liu WE, Jian ZJ, Gao Q, Ling TK, Chow V, So E, Chan R, Hardy K, Xu L, Manzoor S (2013) Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia? J Clin Microbiol 51(10):3308–3313PubMedCrossRefPubMedCentralGoogle Scholar
- 25.Zhang Y, Wang X, Liu L, Cai N, Li Q, Wu K (2010) The anti-diarrhea mechanisms of berberine in diarrhea disease. Shaanxi Med J 39(1):6–8Google Scholar
- 27.He C, Gao P (2010) Meta-analysis of antibiotic-associated diarrhea treated by traditional Chinese medicine. Chin J TCM WM Crit Care 17(2):69–72Google Scholar
- 28.Shu Q, Peng S, Feng Y, Zhang Z, Xie Y, Zhou S (2013) The influences of Chinese herbal compounds on in vitro expression of toxic genes tcdA/tcdB of Clostridium difficile. Chin J Microecol 25(4):373–375, 380Google Scholar